yet inactive in opposition to other host microbiota including Actinobacteria or Bacteroidetes. Ibezapolstat was minimally absorbed in the hamster model, bringing about large colonic and low systemic concentrations, and was also shown to get productive for CDI.ten Preclinical safety testing demonstra